Navigation Links
When nano may not be nano
Date:9/13/2009

DURHAM, N.C. The same properties of nanoparticles that make them so appealing to manufacturers may also have negative effects on the environment and human health.

However, little is known which particles may be harmful. Part of the problem is determining exactly what a nanoparticle is.

A new analysis by an international team of researchers from the Center for the Environmental Implications of NanoTechnology (CEINT), based at Duke University, argues for a new look at the way nanoparticles are selected when studying the potential impacts on human health and the environment. They have found that while many small particles are considered to be "nano," these materials often do not meet full definition of having special properties that make them different from conventional materials.

Under the prevailing definition, a particle is deemed nano if its diameter is between 1 and 100 nanometers (nm) about 1/10,000 the diameter of a human hair and if it has properties that significantly differ from its naturally occurring, or bulk, counterpart.

The special properties of nanoparticles come from their high surface-area-to-volume ratio. They also have a considerably higher percentage of atoms on their surface compared to bulk particles, which can make them more reactive. These man-made materials can be found in a vast array of consumer products, including paints and sunscreens, as well as in water treatment plants and drug delivery systems.

For most of this decade, discussions of nanoparticles have tended to focus more on their size than their properties. However, after reviewing the scientific literature, the Duke-led team believes that the old definition is not specific enough. A definition that focuses on properties is critical, they say, to help scientists determine which particular nanoparticles are the most likely to represent a threat to the environment or human health.

Generally speaking, it is the very smallest particles (less than 30 nanometers) that should receive the most attention in studying the environmental and human health impacts of nanomaterials, according to Mark Wiesner, a Duke professor of civil and environmental engineering and director of the federally funded CEINT.

"There are an infinite number of potential new man-made nanoparticles, so we need to find a way to narrow our efforts to those that have the greatest likelihood of having the unique properties with unique effects," Wiesner said.

"A key question to be answered is whether or not a particular nanoparticle has toxic or hazardous properties that are truly different from identical particles in their bulk form," Wiesner continued. "This question has not been answered. To do so, we need to be speaking the same language when assessing any unique properties of these novel materials."

The results of Wiesner's analysis were published online in the journal Nature Nanotechnology. The study was supported by CEINT, which is jointly funded by the National Science Foundation and Environmental Protection Agency.

Specifically, the researchers found that nanoparticles approaching the 100 nm end of the size spectrum tend to have fewer special properties when compared to their bulk counterparts. Furthermore, they found that nanoparticles smaller than 30 nm tend to exhibit the unique properties that should command increased scrutiny, Wiesner said.

"Many nanoparticles smaller than 30 nanometers undergo drastic changes in their crystalline structure that enhance how the atoms on their surface interact with the environment," Wiesner said.

For example, because of the increased surface-area-to-volume ratio, nanoparticles can be highly reactive with other chemicals in the environment and can also disrupt certain activities within cells.

"While there have been reports of nanoparticle toxicity increasing as the size decreases, it is still uncertain whether this increase in reactivity is harmful to the environment or human safety," Wiesner said. "To settle this issue, toxicological studies should contrast particles that exhibit novel size-dependant properties, particularly concerning their surface reactivity, and those particles that do not exhibit these properties."


'/>"/>

Contact: Richard Merritt
richard.merritt@duke.edu
919-660-8414
Duke University
Source:Eurekalert  

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
When nano may not be nano
(Date:11/28/2016)... 28, 2016 "The biometric ... 16.79%" The biometric system market is in the ... the near future. The biometric system market is expected ... at a CAGR of 16.79% between 2016 and 2022. ... biometric technology in smartphones, rising use of biometric technology ...
(Date:11/22/2016)... , Nov. 22, 2016   MedNet Solutions ... the entire spectrum of clinical research, is pleased to ... Medical LiveWire Healthcare and Life Sciences Awards as ... caps off an unprecedented year of recognition and growth ... for over 15 years. iMedNet ...
(Date:11/17/2016)... Global Market Watch: Primarily supported by ownership types; ... Academics) market is to witness a value of US$37.1 billion ... Compounded Annual Growth Rate (CAGR) of 10.75% is foreseen from ... 2014-2020. North America is not way ... Europe at 9.56% respectively. Report Focus: ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... ... 2016 , ... KBioBox llc announced today the launch of ... a sophisticated “3 click” gene dditing off target analysis program and a “3 ... https://www.kbiobox.com/ and powered by the company’s proprietary BioEngine. Scientists, pharmaceutical researchers ...
(Date:12/8/2016)... , Dec. 8, 2016  Soligenix, Inc. ... biopharmaceutical company focused on developing and commercializing products ... unmet medical need, announced today the long-term follow-up ... SGX942 (dusquetide), a first-in-class Innate Defense Regulator (IDR), ... head and neck cancer patients undergoing chemoradiation therapy ...
(Date:12/8/2016)... , Dec. 8, 2016 Eutilex Co. ... billion KRW (US $18.9M) Series A financing. This financing ... G.N. Tech Venture and SNU Bio Angel. This new ... 30.5 billion KRW (US $27.7M) since its founding in ... to bolster the development and commercialization of its immuno-oncology ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... has concluded that “in the setting of previously treated, advanced pancreatic cancer, liquid ... defining the optimal patient population and timing of blood sampling may improve the ...
Breaking Biology Technology: